Literature DB >> 3883268

Sonographically monitored amniocentesis to decrease intraoperative complications.

R Romero, P Jeanty, E A Reece, P Grannum, M Bracken, R Berkowitz, J C Hobbins.   

Abstract

The rates of intraoperative complications (dry and bloody taps) of two amniocentesis techniques were compared in 1300 patients undergoing second trimester procedures for genetic indications. The sonographically guided technique consisted of the selection of a site for needle insertion with ultrasound, removal of the transducer, and immediate amniocentesis. The sonographically monitored technique consisted of the continuous visualization of the needle during the entire procedure. Six hundred twelve amniocenteses were performed with the sonographically guided technique and 688 with the sonographically monitored technique. There was a statistically significant decrease in the incidence of bloody and dry taps of the first needle insertion (relative risk = 38%, P less than .0001) and also in the number of patients that required multiple needle insertions (relative risk = 42%, P less than .0001) with the sonographically monitored technique.

Entities:  

Mesh:

Year:  1985        PMID: 3883268

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Effect of chorionic villus sampling and early pregnancy counselling on uptake of prenatal diagnosis.

Authors:  P D Knott; R H Ward; M K Lucas
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

Review 2.  Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.

Authors:  Chong Jai Kim; Roberto Romero; Piya Chaemsaithong; Noppadol Chaiyasit; Bo Hyun Yoon; Yeon Mee Kim
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

3.  Giants in Obstetrics and Gynecology Series: Philippe Jeanty, MD, PhD, a pioneer in the study of fetal anatomy, biometry, growth, and congenital anomalies.

Authors:  Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2021-04-05       Impact factor: 10.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.